Dear Colleague,

We are pleased to announce you that the 10th Workshop on Innovative Mouse Models (IMM2019) will be held on June 19-21, 2019 at the Leiden University Medical Center in Leiden, The Netherlands.

REGISTRATION IS OPEN!

[cid:image001.png@01D4FB6E.203007E0] The goal of IMM2019 is to bring together a diverse group of scientists interested in all aspects of advanced mouse experiments within current ethical standards, including key developers of emerging technologies as well as researchers who wish to apply and assess these new approaches. The workshop encourages an in-depth and unvarnished discussion of novel developments in the fields of mouse modeling, addressing the topics:

* How to make genetically-engineered mice in the CRISPR/Cas9 era? * Novel in vivo applications of CRISPR/Cas9 technology * Advanced imaging and phenotyping * How to deal with the mouse microbiota? * Closing debate: the future of mouse models in fundamental and/or translational research

Speakers: Hellmut Augustin (Deutsches Krebsforschungszentrum, Heidelberg) Sylvia Boj (Hubrecht Organoid Technology, Utrecht) Lukas Dow (Weill Cornell Medicine, New York) Channabasavaiah B. Gurumurthy (Nebraska Medical Center, Omaha) Mark Henkelman (Mouse Imaging Centre, Toronto) Yann Herault (Institut Génétique Biologie Moléculaire Cellulaire, Illkirch) Floor Hugenholtz (Microbiota Center Amsterdam, Amsterdam) Ivo Huijbers (The Netherlands Cancer Institute, Amsterdam) Reza Kalhor (Harvard Medical School, Boston) Arthur Liesz (University Medical Center Munich, Munich) Jacco van Rheenen (The Netherlands Cancer Institute, Amsterdam) Els Robanus-Maandag (Leiden University Medical Centre, Leiden) Christine Mummery (Leiden University Medical Centre, Leiden) Keiichiro Suzuki (Osaka University, Osaka) Mihail Todorov (Ludwig Maximilian University of Munich, Munich) Søren Warming (Genentech, South San Francisco) Lin Wu (Harvard University) Branko Zevnik (CECAD Cologne, Cologne)

IMM2019 is a unique opportunity for young researchers to share their experiences. Thus, we encourage you to submit an abstract! 4-5 abstracts will be selected for brief oral presentations.

[IMPORTANT INFORMATION: - Early-bird registration fee: 200 € (deadline: April 26, 2019) - Late registration fee: 250 € (deadline: May 19, 2019) - ISTT membership provides a reduction of 30 € - Registration fee includes lunches and dinners - Abstract submission closes: May 19, 2019]

REGISTER NOW at www.immworkshop.nlhttp://www.immworkshop.nl

Please spread the word and kindly forward this email to your colleagues.

We hope to meet you at the IMM2019 in Leiden!

Sincerely, The IMM2019 Organizers

Ivo Huijbers (Netherlands Cancer Institute, Amsterdam) Peter Hohenstein (LUMC, Leiden) Jos Jonkers (Netherlands Cancer Institute, Amsterdam) Paul Krimpenfort (Netherlands Cancer Institute, Amsterdam) Hein te Riele (Netherlands Cancer Institute, Amsterdam) Els Robanus-Maandag (LUMC, Leiden) Marian van Roon (Animal Research Center (ARC) Poonawalla Science Park B.V. Bilthoven) Anna Gandaglia (Netherlands Cancer Institute, Amsterdam)

[LUMC_logo] [NKI logo] [Poonawalla Logo]

The workshop is supported by [logo-infrafrontier]

[ISTTlogo1][EACR square for web use transparent]

[cid:image020.jpg@01D4ED78.E1624800]

The Netherlands Cancer Institute | Plesmanlaan 121 | 1066 CX AMSTERDAM | www.nki.nlhttp://www.nki.nl/

This e-mail is intended for the addressee(s) eyes only. If you are not the intended recipient, you are hereby kindly requested to inform the sender of this. In view of the electronic nature of this communication, The Netherlands Cancer Institute (NKI) is neither liable for the proper and complete transmission of the information contained therein nor for any delay in its receipt. For information about the Netherlands Cancer Institute, go to www.nki.nlhttp://www.nki.nl/.

Dit e-mailbericht is uitsluitend bestemd voor de geadresseerde(n). Als dit bericht niet voor u bestemd is, wordt u vriendelijk verzocht dit aan de afzender te melden. Het Antoni van Leeuwenhoek (AVL) staat door de elektronische verzending van dit bericht niet in voor de juiste en volledige overbrenging van de inhoud, noch voor tijdige ontvangst daarvan. Voor informatie over het AVL raadpleegt u www.avl.nlhttp://www.avl.nl/